Reimbursement decisions in health policy—extending our understanding of the elements of decision-making
- 8 September 2005
- journal article
- Published by Elsevier in Health Policy
- Vol. 73 (3) , 330-338
- https://doi.org/10.1016/j.healthpol.2004.12.002
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- What constitutes evidence in hospital new drug decision making?Social Science & Medicine, 2004
- Understanding the Role of “the Hidden Curriculum” in Resource Allocation—The Case of the UK NHSHealth Care Analysis, 2003
- Drug reimbursement in Finland—a case of explicit prioritising in special categoriesHealth Policy, 2003
- Determinants of HMO Formulary Adoption DecisionsHealth Services Research, 2003
- Managing the entry of new medicines in the National Health Service: health authority experiences and prospects for primary care groups and trustsHealth & Social Care in the Community, 2001
- Priority-setting decisions for new cancer drugs: a qualitative case studyThe Lancet, 2001
- Rationing health care: an explorationHealth Policy, 1999
- Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence thresholdBMJ, 1999
- Rationing and the health authorityBMJ, 1998
- Drug Formularies: Myths-ln-FormationMedical Care, 1990